ArticleJournal for immunotherapy of cancer2021

Prospective development and validation of a liquid immune profile-based signature (LIPS) to predict response of patients with recurrent/metastatic cancer to immune checkpoint inhibitors.

Jian-Guo Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.